Dr. Hsu received his BS and MS from National Taiwan University. He obtained his PhD from Duke University in Biochemistry, where he discovered and characterized translational regulation and RNA localization in Dr. Christopher Nicchitta’s lab. Dr. Hsu is doing his postdoctoral training at Yale University in the groups of Drs. Peter Cresswell and Maudry Laurent-Rolle, where he investigates translational regulation in innate immunity and SARS-CoV-2 infection. At Yale, Dr. Hsu has set up five technologies for translation studies, including ribosome sequencing (Ribo-seq), polysome profiling, and three systems based on protein and nascent chain labelings: [35S]-methionine metabolic labeling, puromycin labeling and O-propargyl-puromycin (OP-Puro) labeling. These technologies will serve as a platform to understand how pathogenic viruses like SARS-CoV-2 and Zika virus shut down host protein synthesis to evade the host antiviral responses.
|K22 Career Transition Award||NIAID||2022|
|Irvington Postdoctoral Fellowship||Cancer Research Institute||2019|
|Ruth L. Kirschstein National Research Service Awards (T32)||2017|